Ipswich Investment Management’s Pfizer PFE Stock Holding History

Ipswich Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Hold	9,121	–	–	0.05%	179
2026 Q1	$256K	Hold	9,121	–	–	0.06%	165
2025 Q4	$227K	Hold	9,121	–	–	0.05%	173
2025 Q3	$232K	Sell	9,121 -4,532	-33%	-$112K	0.05%	172
2025 Q2	$331K	Hold	13,653	–	–	0.08%	143
2025 Q1	$346K	Sell	13,653 -2,475	-15%	-$64.8K	0.09%	138
2024 Q4	$428K	Sell	16,128 -1,551	-9%	-$42.1K	0.1%	129
2024 Q3	$512K	Sell	17,679 -310	-2%	-$9.04K	0.12%	123
2024 Q2	$503K	Sell	17,989 -1,905	-10%	-$52.4K	0.12%	123
2024 Q1	$552K	Sell	19,894 -2,947	-13%	-$81.8K	0.13%	123
2023 Q4	$658K	Sell	22,841 -2,601	-10%	-$78.6K	0.17%	109
2023 Q3	$844K	Sell	25,442 -75	-0.3%	-$2.65K	0.23%	95
2023 Q2	$936K	Sell	25,517 -450	-2%	-$17.5K	0.25%	92
2023 Q1	$1.06M	Sell	25,967 -250	-1%	-$10.8K	0.29%	83
2022 Q4	$1.34M	Sell	26,217 -74	-0.3%	-$3.55K	0.38%	72
2022 Q3	$1.15M	Sell	26,291 -9,300	-26%	-$452K	0.37%	73
2022 Q2	$1.87M	Sell	35,591 -316	-0.9%	-$16.1K	0.54%	58
2022 Q1	$1.86M	Sell	35,907 -45	-0.1%	-$2.33K	0.46%	66
2021 Q4	$2.12M	Buy	35,952 +1,000	+3%	+$49.5K	0.5%	61
2021 Q3	$1.5M	Buy	34,952 +100	+0.3%	+$4.43K	0.38%	76
2021 Q2	$1.36M	Sell	34,852 -95	-0.3%	-$3.69K	0.35%	80
2021 Q1	$1.27M	Sell	34,947 -91	-0.3%	-$3.23K	0.36%	81
2020 Q4	$1.29M	Sell	35,038 -3,325	-9%	-$122K	0.39%	70
2020 Q3	$1.34M	Buy	38,363 +445	+1%	+$15.6K	0.43%	65
2020 Q2	$1.18M	Sell	37,918 -11,172	-23%	-$380K	0.41%	62
2020 Q1	$1.52M	Buy	49,090 +5,713	+13%	+$195K	0.6%	53
2019 Q4	$1.61M	Sell	43,377 -101	-0.2%	-$3.6K	0.47%	59
2019 Q3	$1.48M	Hold	43,478	–	–	0.47%	59
2019 Q2	$1.79M	Sell	43,478 -579	-1%	-$23K	0.57%	53
2019 Q1	$1.77M	Buy	44,057 +863	+2%	+$34.6K	0.58%	53
2018 Q4	$1.79M	Buy	43,194 +4,851	+13%	+$201K	0.66%	46
2018 Q3	$1.6M	Buy	38,343 +1,718	+5%	+$66.1K	0.54%	61
2018 Q2	$1.26M	Buy	36,625 +938	+3%	+$32.1K	0.58%	57
2018 Q1	$1.2M	Buy	35,687 +332	+0.9%	+$11.4K	0.51%	57
2017 Q4	$1.22M	Sell	35,355 -264	-0.7%	-$9K	0.51%	56
2017 Q3	$1.21M	Sell	35,619 -933	-3%	-$30K	0.54%	49
2017 Q2	$1.17M	Buy	36,552 +3,663	+11%	+$116K	0.55%	55
2017 Q1	$1.07M	Sell	32,889 -63	-0.2%	-$1.99K	0.46%	58
2016 Q4	$1.01M	Sell	32,952 -1,739	-5%	-$53.1K	0.46%	59
2016 Q3	$1.11M	Buy	34,691 +2,724	+9%	+$91.1K	0.55%	54
2016 Q2	$1.07M	Hold	31,967	–	–	0.53%	57
2016 Q1	$1.03M	Buy	31,967 +1,687	+6%	+$48.2K	0.49%	58
2015 Q4	$927K	Sell	30,280 -1,160	-4%	-$36.5K	0.42%	60
2015 Q3	$937K	Buy	31,440 +13,218	+73%	+$424K	0.45%	58
2015 Q2	$580K	Sell	18,222 -4,889	-21%	-$159K	0.26%	80
2015 Q1	$763K	Hold	23,111	–	–	0.33%	69
2014 Q4	$683K	Hold	23,111	–	–	0.29%	72
2014 Q3	$648K	Sell	23,111 -13,070	-36%	-$367K	0.28%	66
2014 Q2	$1.02M	Buy	36,181 +10,962	+43%	+$312K	0.4%	57
2014 Q1	$769K	Sell	25,219 -14,860	-37%	-$443K	0.33%	63
2013 Q4	$1.17M	Hold	40,079	–	–	0.49%	55
2013 Q3	$1.09M	Sell	40,079 -1,205	-3%	-$32.8K	0.49%	57
2013 Q2	$1.1M	Buy	+41,284	New	+$1.14M	0.47%	60

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ipswich Investment Management's PFE Position: Q2 2026 in Review

Ipswich Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 9,121 shares worth $220K. The position accounts for 0.05% of the portfolio, ranked #179.

Ipswich Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.12M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ipswich Investment Management held 9,121 shares of Pfizer worth $220K as of Q2 2026.
Ipswich Investment Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.05% of Ipswich Investment Management's portfolio in Q2 2026, its #179 holding.
Ipswich Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Ipswich Investment Management's Pfizer position peaked at $2.12M in Q4 2021.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.